Pharmafocus Home
    
Keyword Search
Go News Archive Features Events Appointments Jobs Contact Us About Us
Latest Features ( October )
A postcard from ... Slovakia
We take a look at how this young country is managing healthcare and controlling costs(more)
The Pharmafocus Interview: Jan Lundberg
AstraZeneca's global head of drug discovery talks about new compounds, learning from mistakes and the real heroes behind life-saving drugs.(more)
Emerging confidence
Evidence-based medicine is an evolving practice, even in the developed world, but proving value is getting tougher in emerging markets too, says Ben Shankland(more)
Pharmafocus.comNews Headlines Register for News Alert
News for October 2008
Previous Months: September 2008 |  August 2008 |  July 2008 |  June 2008 |  May 2008 |  April 2008 |  March 2008 |  February 2008 |  January 2008 |  December 2007 |  November 2007 |  October 2007 |  September 2007 |  August 2007 |  July 2007 |  June 2007 |  May 2007 |  April 2007 |  March 2007 |  February 2007 |  January 2007 |  December 2006 |  November 2006 |  October 2006 |  September 2006 |  August 2006 |  July 2006 |  June 2006 |  May 2006 |  April 2006 |  March 2006 |  February 2006 |  January 2006 |  December 2005 |  November 2005 |  October 2005 |  September 2005 |  August 2005 |  July 2005 |  June 2005 |  May 2005 |  April 2005 |  March 2005 |  February 2005 |  January 2005 |  December 2004 |  November 2004 |  October 2004 |  September 2004 |  August 2004 |  July 2004 |  June 2004 |  May 2004 |  April 2004 |  March 2004 |  February 2004 |  January 2004 |  December 2003 |  November 2003 |  October 2003 |  September 2003 |  August 2003 |  July 2003 |  June 2003 |  May 2003 |  April 2003 |  March 2003 |  February 2003 |  January 2003 |  December 2002 |  November 2002 | 

  What is RSS?

England's mental health policy leading Europe, says WHO
Last 10 years have seen a transformation..(more)

 Novartis pursues pulmonary hypertension indication for Glivec
Drug's potential in pulmonary arterial hypertension will be further explored next year..(more)

 Lilly eyes oncology focus with ImClone acquisition
Trumps Bristol-Myers Squibb bid with $6.5 billion offer..(more)

 GlycArt's new cancer candidate to be developed with Roche
GA101 already in phase I/II clinical trials for CD20-positive B-cell malignancies..(more)

 UK is example to Europe on patient information, says industry
Liberal environment allows close pharma-stakeholder relations..(more)

 Advertising start-up is UK's 'first virtual healthcare agency'
Internet-based service will offer greener, flexible, cost-effective advertising..(more)

 Latest news from Datamonitor
Does Rx-to-OTC protect revenues and cut healthcare costs? ..(more)

 Norgine quits ABPI and denounces big pharma bias
Company blames PPRS pricing negotiations for exit..(more)

 GSK plans research job losses in UK
Worldwide around 850 positions set to be cut..(more)

 Merck obesity drug fails in phase III
Late-stage failure for company as taranabant abandoned ..(more)

 Spiriva partners defend drug's safety
Boehringer Ingelheim and Pfizer release new data on the COPD treatment..(more)

 Osteoporosis drug Aclasta approved for use in men
Novartis treatment extends its European licence..(more)

 Long-acting Zyprexa gets green light
EC advisors recommend Lilly's schizophrenia drug..(more)

 MHRA unveils medicine information resource
Regulator partners with ABPI on drug lifecycle website..(more)

 Credit crunch hits European biotech
Small and medium-sized companies being starved of funding..(more)

 Weak currency helps UK pharmaceutical industry
Competition from European parallel imports falls..(more)

Are you a Pharmafocus subscriber?

Subscribe Now 

Visit our sister sites: 

InPharm.com 

Pharmafile.com 

Pharmafocus.com © 2006 Pharmafile Ltd.